HOPA members visiting the exhibit hall at annual conference

Industry Relations Council

HOPA's signature opportunity for industry support continues to be our Industry Relations Council (IRC), complete with benefits such as high visibility at conferences and events. Click here to learn more.

IRC participation is open to all organizations that support HOPA's mission and goals. Contact Laurie Rappa, Senior Development Manager at 877.467.2791 or lrappa@hoparx.org with inquiries.

Spacer Image

HOPA 2025 Annual Conference

HOPA Annual Conference 2025 (HOPA 2025) takes place April 9-12 at the Oregon Convention Center in Portland, Oregon. This conference is known for its late-breaking and diverse content delivered by oncology pharmacy professionals who are experts in optimizing care of patients with cancer and hematologic conditions.

HOPA 2025 Conference Highlights

  • We anticipate approximately 1,500 oncology pharmacy professionals to attend
  • Attendees will have ample learning opportunities, including 34 ACPE credits and 8 BCOP credits
  • HOPA 2025 will host two preconference sessions, focusing on leadership development and chemotherapy toxicity (each session provides an additional 4 ACPE credit hours)
  • Conference sessions will be of interest to both general and sub-specialist hematology/oncology pharmacists, focusing on a wide variety of cancers including pediatric cancers, NSCLC, and CLL
    • Topics will cover various treatment types, including cellular therapy and novel therapies, as well as practice management learning
  • Additional topics include supportive care management and clinical practice updates on several disease states

In addition to all the great science delivered in plenary and breakout sessions, and presented in posters and abstracts, we also look forward to networking with members, colleagues, and industry partners like you!

Many Ways to Support HOPA's Annual Conference

Many opportunities are available on a first come first served basis. If you're ready to get started, please complete our sponsorship form. The last day to reserve HOPA 2025 Annual Conference opportunities is March 14, 2025.

HOPA 2025 Sponsorship Form

Spacer Image conversation in a symposia room Spacer Image

HOPA 2025 Opportunities

Thank you for considering these opportunities:

  • Become a conference sponsor
  • Promote your company and products in the Exhibit Hall
  • Present a CE or Non-CE Symposia (sold out for 2025)
  • Be Visible – Check out in person and online advertising opportunities

At nearly 4,000 members strong, HOPA is 100% dedicated to supporting oncology pharmacists and optimizing patient care. We believe everyone undergoing cancer treatment should have an oncology pharmacist as an integral member of their care team. Through robust education and professional development, active advocacy, and industry support, our members are poised to make that vision a reality.

Spacer Image exhibit hall entrance

HOPA 2025 Annual Conference Prospectus

Thank you for your interest in HOPA’s Annual Conference 2025. Our full 2025 prospectus is available now. It will provide you with information to get involved and get the attention of an important target audience. If you would like to be added to our conference contact mailing list or request a copy of the prospectus, please email development@hoparx.org.

Reserve your HOPA 2025 Annual Conference Sponsorship Opportunities

Many opportunities are limited and filling up fast. Reserve your spot now!

Last day to secure opportunities for HOPA 2025 Annual Conference is March 14, 2025.

Contact

If you have any questions or would like more information on a customized sponsorship package please contact the HOPA Development Team at development@hoparx.org.

grey

Practice Management Webinar Series

In November, HOPA will host our first in a series of Virtual Practice Management Webinars.

Having reimagined HOPA's Practice Management (PM) to be offered four times a year, we look forward to providing leadership, partners, and members, PM educational content and continuing education credits with a few extra perks and added lifestyle convenience.

Designed to Keep Practice Managers, Managing Their Practice

As a virtual series we have removed travel time, the need for time off, and defrayed the cost of in-person learning, without forfeiting what HOPA is known for: great PM content and speakers - just more frequently! Click here to learn more about the series.

Your Sponsorship of the entire series or individual webinar sessions is key to our virtual PM program's success!

The first webinar in the series is "Operationalizing Bispecific Therapies: From Engaging T-cells to Care Teams" November 12, 2024, from 1:00–2:30pm CT.

Sponsorship benefits include banner ads, logo recognition, and name recognition.

grey

Evergreen Opportunities

Connect with HOPA Members in meaningful ways through our many events and opportunities. HOPA provides the latest, most pertinent information in the field. Our members are highly trained decision makers who are actively engaged in medication management and business decisions because of the distinctive demands and challenges of this specialized profession. HOPA is a unique organization that attracts a blend of clinicians, educators, researchers, and administrators and is committed to helping practitioners navigate the rapidly changing world of oncology practice. Our ongoing commitment to provide information to our members regularly reaches over 3,500 members through our print and digital resources.

Advertise with HOPA through our newsletters, eBlasts, mailing list rentals, and more.

The importance of industry support

HOPA's Time to Talk initiative

One example of what HOPA is able to achieve with a little bit of support is the Time to Talk Initiative.

Learn more about our past time to talk campaigns: Time to Talk Immuno-Oncology™ or CINV: Time to Talk Public Service Announcement for Adults 55+

HOPA's next Time to Talk campaign will focus on diversity in clinical trials.
If your company is interested in supporting this campaign reach out to development@hoparx.org for more information.

Rob Carauno testimonial about Time to Talk

Jeremy Whalen discussing Industry as a Career

HOPA Member, Jeremy Whalen, PharmD, BCOP, Medical Affairs Executive Director for Genentech discusses the intersection of a career in industry and his commitment to HOPA.